Inventor

PERRICAUDET MICHEL

FR38 patents

⚠️ This page may combine multiple inventors who share the name “PERRICAUDET MICHEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PERRICAUDET MICHEL

AVENTIS PHARMA SA

Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses

Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain

Targeted adenovirus vectors for delivery of heterologous genes

Defective adenoviruses including a therapeutic gene and an immunoprotectove gene

Method for producing recombinant virus

Composition for the in vivo production of therapeutic products

Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF)

Gene therapy for restenosis using an adenoviral vector

Methods and compositions for producing viral particles

Recombinant adenoviruses containing an inducible promoter controlling a gene of viral origin

Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias

Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF)

Viable contaminant particle free adenoviruses, their preparation and use

Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same

Assays for promoter operability in central nervous system cells

RHONE POULENC RORER SA

Cells for the production of recombinant adenoviruses

Method for preparing recombinant adeno-associated viruses (AAV), and uses thereof

Recombinant adero viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias

Viable contaminant particle free adenoviruses, their prepartion and use

Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof

Adenoviral vectors of canine origin

Recombinant adenoviruses for gene therapy in cancers

Defective recombinant adenoviruses with inactivated IVa2 gene

CENTRE NAT RECH SCIENT

Defective recombinant adenoviruses expressing cytokines for antitumor treatment

Defective recombinant adenoviruses expressing cytokines for antitumor treatment

Viral recombinant vectors for expression in muscle cells

Viral recombinant vectors for expression in muscle cells

GENCELL SA

Generating replicating molecules in vivo

Recombinant adenoviruses for gene therapy in cancers

PASTEUR INSTITUT

Adenoviral vector with a deletion in the E1A coding region expressing a hetorologous protein

Defective recombinant adenovirus lacking E1A coding sequence and comprising a heterologous nucleotide sequence under control of the E1A promoter

US HEALTH

Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung

TRANSGENE SA

Replication deficient recombinant adenovirus vector

INST NAT SANTE RECH MED

Recombinant cells from the monocyte-macrophage cell line for gene therapy

GENCELL SAS

Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors

BENIHOUD KARIM

Adenovirus vaccine vectors

INST DI RICERCHE DI BIOLOGGIA

Adenoviral vectors for mutants of human interleukin 6 (hIL-6) with hIL-6 antagonist activity, pharmaceutical compositions therewith and their uses

PERRICAUDET MICHEL

Recombinant adenoviruses encoding the specific iodine transporter (NIS)